flufenamic acid has been researched along with Osteosarcoma in 2 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passeri, G | 1 |
| Northcote-Smith, J | 1 |
| Perera, R | 1 |
| Gubic, N | 1 |
| Suntharalingam, K | 1 |
| Rodan, SB | 1 |
| Rodan, GA | 1 |
| Simmons, HA | 1 |
| Walenga, RW | 1 |
| Feinstein, MB | 1 |
| Raisz, LG | 1 |
2 other studies available for flufenamic acid and Osteosarcoma
| Article | Year |
|---|---|
An Osteosarcoma Stem Cell Potent Nickel(II)-Polypyridyl Complex Containing Flufenamic Acid.
Topics: Bone Neoplasms; Cell Line, Tumor; Coordination Complexes; Cyclooxygenase 2; Flufenamic Acid; Humans; | 2022 |
Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2.
Topics: Animals; Bone Neoplasms; Bone Resorption; Cell Line; Chromatography, Thin Layer; Culture Media; Dino | 1981 |